Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 18/20 | 0.48 |
| ▸ | WNT1 | P04628 | 10/20 | 0.48 |
| ▸ | CLK2 | P49760 | 5/20 | 0.48 |
| ▸ | CLK3 | P49761 | 4/20 | 0.48 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | PARP1 | P09874 | 1/20 | 0.45 |
| ▸ | DHODH | Q02127 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6584525 | 0.84 | DYRK1A (0.50) | DYRK1AWNT1CLK2CLK3GSK3B | |
| Fumaric Acid SCHEMBL8552190 | 0.80 | DYRK1A (0.48) | DYRK1AWNT1CLK2CLK3GSK3B | |
| Fumaric Acid SCHEMBL6587886 | 0.80 | DYRK1A (0.48) | DYRK1AWNT1CLK2CLK3GSK3B | |
| SCHEMBL6584434 | 0.78 | DYRK1A (0.50) | DYRK1AWNT1CLK2CLK3GSK3B | |
| SCHEMBL6583163 | 0.77 | DYRK1A (0.44) | DYRK1AWNT1CLK2CLK3GSK3B | |
| SCHEMBL6971264 | 0.73 | CHRNB4 (0.43) | — | |
| Fumaric Acid SCHEMBL6584532 | 0.73 | DYRK1A (0.50) | DYRK1AWNT1CLK2CLK3GSK3B | |
| Fumaric Acid SCHEMBL6592877 | 0.72 | DRD2 (0.52) | DYRK1AWNT1CLK2CLK3GSK3B | |
| Fumaric Acid SCHEMBL6592880 | 0.72 | DRD2 (0.52) | DYRK1AWNT1CLK2CLK3GSK3B | |
| SCHEMBL6584206 | 0.71 | DRD2 (0.56) | DYRK1AWNT1CLK2CLK3GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0871615-B1 | SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS | MERCK & CO INC (US) | 2004-07-14 | — | — | EP | disclosed |
| US-6194581-B1 | FOR TREATMENT OF DYSFUNCTION OF THE CENTRAL OR AUTONOMIC NERVOUS SYSTEMS INCLUDING DEMENTIA, COGNITIVE DISORDERS, NEURODEGENERATIVE DISORDERS, EXTRAPYRAMIDAL DISORDERS, CONVULSIVE DISORDERS, CARDIOVASCULAR DISORDERS, PAIN | MERCK & CO., INC. | 2001-02-27 | — | — | US | disclosed |
| US-5852041-A | Substituted pyridines useful as modulators of acethylcholine receptors | SIBIA NEUROSCIENCES, INC. (US) | 1998-12-22 | — | — | US | disclosed |
| EP-0871615-A1 | SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS | SIBIA NEUROSCIENCES, INC. (US) | 1998-10-21 | — | — | EP | disclosed |
| US-5736560-A | USEFUL IN THE TREATMENT OF ALZHEIMER'S AND PARKINSONS'S DISEASES | SIBIA NEUROSCIENCES, INC. (US) | 1998-04-07 | — | — | US | disclosed |
| US-5686473-A | TREATING PARKINSON*S DISEASE, ALZHEIMER*S DISEASE, DEMENTIA AND PAIN | SIBIA NEUROSCIENCES, INC. (US) | 1997-11-11 | — | — | US | disclosed |
| WO-1996031475-A2 | SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS | SIBIA NEUROSCIENCES, INC. (US) | 1996-10-10 | — | — | WO | disclosed |